Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia. The ...
William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating today. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily ...
JPMorgan raised the firm’s price target on Cellebrite (CLBT) to $24 from $22 and keeps an Overweight rating on the shares. The firm updating ...
Serbian officials installed homegrown spyware on the phones of dozens of journalists and activists, Amnesty International ...
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are currently covering the company, Marketbeat.com ...